55
Views
15
CrossRef citations to date
0
Altmetric
Original Research

The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up

, , , , , , & show all
Pages 2655-2664 | Published online: 22 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinran Li, Jiamin Zheng, Min Yan, Ye Lu & Xiangtao Pan. (2022) The Significance of Fibrinogen in Combination with the Neutrophil to Lymphocyte Ratio in Predicting the Prognosis of Patients with Gastric Cancer. Cancer Management and Research 14, pages 2313-2321.
Read now

Articles from other publishers (14)

Ning Zhou, Fan Zhang & Cong Chen. (2022) Matrine Promotes Dendritic Cell Activation and Enhances Anti-tumor Effect of Human Gastric Carcinoma Dendritic Cells Vaccine in Vitro. Acupuncture & Electro-Therapeutics Research 47:4, pages 391-401.
Crossref
Dragos SerbanNikolaos Papanas, Ana Maria Dascalu, Peter KemplerItamar RazAli A. Rizvi, Manfredi RizzoCorneliu TudorMihail Silviu Tudosie, Denisa TanasescuAnca Pantea StoianEvanthia GouveriDaniel Ovidiu Costea. (2021) Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets. The International Journal of Lower Extremity Wounds, pages 153473462110577.
Crossref
Benjamin Pradere, David D’Andrea, Victor M. Schuettfort, Beat Foerster, Fahad Quhal, Keiichiro Mori, Mohammad Abufaraj, Vitaly Margulis, Marine Deuker, Alberto Briganti, Tim Muilwijk, Kees Hendricksen, Yair Lotan, Pierre Karakiewic & Shahrokh F.Shariat. (2020) Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma. World Journal of Urology 39:7, pages 2567-2577.
Crossref
Kei Suzuki & Virginia R. Litle. (2020) Don’t Anger the Host: New Etiquette in Standard Cancer Assessment?. Annals of Surgical Oncology 28:2, pages 598-599.
Crossref
Yuanfu Luo, Renzhi Deng, Qiulu Zhong, Danjing Luo, Xiangde Li, Xueyuan Chen, Sha Tao, Zhoubin Feng, Liu Jiayi, Yiyun Huang, Jian Li & Wenqi Liu. (2021) The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments. Medicine 100:25, pages e26437.
Crossref
Qiong Li, Lin-Yi Huang & Hui-Ping Xue. (2020) Comparison of prognostic factors in different age groups and prognostic significance of neutrophil-lymphocyte ratio in patients with gastric cancer. World Journal of Gastrointestinal Oncology 12:10, pages 1146-1166.
Crossref
Ziyu Li, Shuangxi Li, Xiangji Ying, Lianhai Zhang, Fei Shan, Yongning Jia & Jiafu Ji. (2020) The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer 23:3, pages 540-549.
Crossref
Jingjing Hou, Yuyu Tan, Chen Su, Tao Wang, Zhixing Gao, Dan Song, Jiabao Zhao, Yueting Liao, Xiaotian Liu, Ying Jiang, Qian Feng, Zhong Wan & Yongsheng Yu. (2020) Inhibition of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma via p53 signaling pathways. Computational and Structural Biotechnology Journal 18, pages 125-136.
Crossref
Peng Li, Wei Huang, Feng Wang, Ye-Fang Ke, Lin Gao, Ke-Qing Shi, Meng-Tao Zhou & Bi-Cheng Chen. (2019) Reply to: Comments on “Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma”. Bioscience Reports 39:12.
Crossref
Fangteng Liu, Hongliang Luo, Zhengming Zhu, Peiqian Zhu & Jun Huang. (2019) Prognostic significance of peripheral blood‐derived neutrophil/lymphocyte ratio in patients with digestive cancer. Journal of Cellular Physiology 234:12, pages 22775-22786.
Crossref
Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki, Naoko Chayahara, Kenji Nakano, Lina Inagaki, Kazuhisa Toda, Tomohiro Enokida, Hironobu Minami, Yoshinori Imamura, Naoki Fukuda, Tatsuya Sasaki, Takuya Suzuki, Hiroki Ikezawa, Corina E Dutcus & Makoto Tahara. (2019) A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer. Future Oncology 15:7, pages 717-726.
Crossref
Guoliang Qiao, Xiaoli Wang, Lei Zhou, Xinna Zhou, Yuguang Song, Shuo Wang, Lei Zhao, Michael A. Morse, Amy Hobeika, Jin Song, Xin Yi, Xuefeng Xia, Jun Ren & Herbert Kim Lyerly. (2019) Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clinical Cancer Research 25:5, pages 1494-1504.
Crossref
Arianna Barbetta, Tamar B. Nobel, Smita Sihag, Meier Hsu, Kay See Tan, Manjit S. Bains, James M. Isbell, Yelena Y. Janjigian, Abraham J. Wu, Matthew J. Bott, David R. Jones & Daniela Molena. (2018) Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer. The Annals of Thoracic Surgery 106:3, pages 864-871.
Crossref
A. Rebonato, L. Graziosi, D. Maiettini, E. Marino, V. De Angelis, L. Brunese, S. Mosca, G. Metro, M. Rossi, G. Orgera, M. Scialpi & A. Donini. (2017) Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Gastroenterology Research and Practice 2017, pages 1-9.
Crossref